Tonix stock: buy or sell?

TNXP stock price: $0.73 5.80% At close on April 6th, 2020

Updated on:
April 6th, 2020

2

Tonix closed today at $0.73 and rocketed an amazing 5.80%. On Wednesday TNXP collapsed a frightening -9.23%. Counting Monday, it's been 3 green days in a row, gaining $0.08 or 11.27%.

Tonix Pharmaceuticals Holding Corp. engages in developing pharmaceutical and biological products to address public health challenges.

Should I buy Tonix stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Tonix stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Tonix stock a buy?

Financial institutions and banks publish stock ratings everyday. Unfortunately, we couldn't detect any rating for TNXP stock for the last month.

Tonix stock analysis

Daily outlook

Tonix shares rocketed 5.80% to $0.73 today.

Tonix shares rocketed 5.80% to $0.73 today. Since price and SMA50d lines crossed down on March/25, TNXP fell $-0.26 per share (-26.26%).

TNXP stock chart (daily)

Weekly outlook

After sliding a dreadful -5.80% in a week last week, Tonix Pharmaceuticals closed this week at $0.73 and rocketed an outstanding 5.80%.

If you observe the weekly chart, price is in a simple uptrend, tested $0.50 level and now climbing back aiming its last top at $1.98. Since late April 2019, when TNXP stock price broke down the 20-weeks moving avarage line, it slid $-21.77 per share (-96.76%).

TNXP stock chart (weekly)

Tonix stock price history

Tonix stock went public on December 4th, 2013 with a price of $6,310.001. Since then, TNXP stock sliced a -100.00%, with a yearly average of -16.70%.

1: Adjusted price after possible price splits or reverse-splits.

Tonix stock historical price chart

TNXP stock reached 52-week highs at $31.40, and all-time highs 2014-01-14 with a price of 18970.

Tonix stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' TNXP stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price prediction for Tonix stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Tonix reported outstanding results for 2018-Q4 . Tonix skyrocketed Earnings per Share (EPS) by 57.60%, beating experts consensus of $-3.87. Tonix posted $-6.10.
TNXP earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/an/an/a
2017-Q2-n/an/an/a
2017-Q32017-11-07-0.7-0.77n/a
2017-Q42018-03-12-7.7-6.7n/a
2018-Q12018-05-14-7-8.8n/a
2018-Q22018-08-13-7.6-7.3n/a
2018-Q32018-11-09-6.5-5.7n/a
2018-Q42019-03-18-3.87-6.1n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In , Tonix Pharmaceuticals annual sales to M USD from marked in . , its earnings margin (compared to revenues) to , that is million.

TNXP annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter income marked $-7.59 M with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Tonix Pharmaceuticals sales marked a tight movement and remained constant a nan%. Looking back to recent quarterly results, Tonix Pharmaceuticals posted 7 negative quarters in a row.
TNXP quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Tonix ownership

When you are planning to buy shares of a company, it's always worth to have a look its ownership structure.

Tonix Pharmaceuticals shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.06% of all shares.

In case of Tonix Pharmaceuticals stock, 6.85% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for TNXP stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Tonix:

TNXP
Market cap$35.9 M
Total shares49.2 M
Float shares1.6 M
  - Institutional holdings (%)6.9%
  - Insider holdings (%)0.1%
Shares in short selling0.0%

Tonix summary

Monday, April 6th, 2020
Open$0.70
Close$0.73
Day range$0.67 - $0.74
Previous close$0.69
Session gain5.80%
Average true range$0.17
50d mov avg$0.86
100d mov avg$1.11
200d mov avg$3.44
Daily patternlt11a
Weekly pattern lb01a

Tonix performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Tonix Pharmaceuticals to :
Stock3m6m12m
TNXPTonix Pharmaceuti...-53.80%-83.02%-97.09%

Tonix competitors

Unfortunately, we could not find any public company that could be defined as Tonix competitor. This doesn't mean Tonix does not have any competitor in the market, it's just we could not detected it.